Clinical Trials Directory

Trials / Terminated

TerminatedNCT00857597

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

A Randomized Controlled Trial of Transoral Incisionless Fundoplication (TIF) Versus Proton Pump Inhibitors (PPIs) for Treatment of GERD: The TIF vs. PPIs Study

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study objective is to evaluate the relative merits, safety and effectiveness of Transoral Incisionless Fundoplication (TIF) in GERD patients currently treated with daily Proton Pump Inhibitors (PPIs).

Conditions

Interventions

TypeNameDescription
PROCEDURETransoral Incisionless FundoplicationThe TIF procedure using the EsophyX system with SerosaFuse fasteners was designed to create full-thickness serosa-to-serosa plications and construct valves of 3-5 cm in length and 200-300° in circumference.
DRUGProton Pump Inhibitors; active controlProton Pump Inhibitors; active control

Timeline

Start date
2009-03-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2009-03-06
Last updated
2018-03-30

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00857597. Inclusion in this directory is not an endorsement.

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment (NCT00857597) · Clinical Trials Directory